This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
fin-tech: Archive
Should You Buy Impinj (PI) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
4 Stocks With Solid Net Profit Margins to Boost Portfolio Returns
by Anirudha Bhagat
Here we present four stocks, HURN, EDRY, ENVA and QUAD, with solid net profit margins that can contribute to making a strong portfolio.
HURNPositive Net Change QUADNegative Net Change ENVANegative Net Change EDRYPositive Net Change
fin-tech finance tech-stocks transportation
Will Pismo-DPS Help Visa Capture More of the Banking Value Chain?
by Rajshree Sipani
V's Pismo-DPS strategy could deepen its banking infrastructure role, expand fintech and bank relationships and broaden its technology footprint.
VPositive Net Change MAPositive Net Change PYPLNegative Net Change
artificial-intelligence business-services fin-tech finance payments saas
PGY Looks Cheap, But Can Growth Outpace Execution and Funding Risks?
by Nikita Kataruka
Pagaya trades below its industry P/B average, while rising earnings estimates and growth face funding-cost and execution risks.
PGYNegative Net Change ENVANegative Net Change AFRMNegative Net Change
artificial-intelligence fin-tech finance
Pagaya Stock Rose 10.4% in a Week, But Can the Rally Continue Now?
by Nikita Kataruka
PGY's 10.4% weekly gain follows stronger earnings, deeper funding and partner growth, but rising costs and concentration risks could test the rally.
PGYNegative Net Change ENVANegative Net Change AFRMNegative Net Change
artificial-intelligence fin-tech finance
StoneX Q3 Earnings Surge as R.J. O'Brien Synergies Move Toward $50M
by Swayta Shah
StoneX posted sharp Q3 earnings growth as R.J. O'Brien synergies reached $38M, with further gains expected despite retail weakness and rising costs.
SNEXNegative Net Change CMEPositive Net Change IBKRNegative Net Change
fin-tech finance
Is SNEX a Buy as Earnings Growth Collides With a Premium Valuation?
by Swayta Shah
StoneX pairs strong earnings growth and expanding scale with a premium valuation, leaving investors to weigh momentum against margin and credit risks.
SNEXNegative Net Change CMEPositive Net Change IBKRNegative Net Change
fin-tech finance
SNEX Drops 14% in One Week: Is the Pullback a Buying Opportunity?
by Swayta Shah
StoneX shares fell 14% in a week despite strong Q3 earnings growth, as valuation, retail weakness and rate sensitivity temper the buying case.
SNEXNegative Net Change CMEPositive Net Change IBKRNegative Net Change
banking fin-tech finance
Jones Lang LaSalle (JLL)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
JLLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Wayfair (W) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
WNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines